Asure Software: Buy The AWS Marketplace Catalyst At A Cheap Revenue Multiple

Asure Software: Buy The AWS Marketplace Catalyst At A Cheap Revenue Multiple

I'm a buyer of Asure Software around $8.50. Not because a channel announcement changes the quarter — it doesn't — but because the market has already discounted the parts of this business it does not like, and the AWS Marketplace launch is the first real distribution catalyst the enterprise payroll-tax story has had since Asure bought its way into that market. Shares rose 3.1% in premarket on the news and settled to a roughly 1.4% gain intraday at about $8.55. That muted reaction is informative: no one is paying for this channel yet, which is exactly the condition under which I want to own a stock like this.

The announcement, and why co-selling is a real step

Asure will begin co-selling its Enterprise Payroll Tax and Treasury solutions through the 330,000-customer AWS Marketplace starting in September. Co-selling matters because of how large enterprises buy software today: purchases made through the AWS Marketplace can be applied against the cloud-spend commitments companies have already made to Amazon, and they get a faster procurement and security-review path than a conventional multi-quarter enterprise software sale. AWS field sellers also have an incentive to bring Asure into deals. The company is doing this with Labra.io, an AWS Premier Tier Services Partner, which manages the listings, transactions, and co-sell process.

What is being sold there is not a speculative product. The enterprise tax business — which handles multi-jurisdiction tax filing, funding, and money movement — already produces nearly 20% of Asure's revenue and serves more than a dozen global brands. The question was never whether the product works; it was whether Asure could reach enough enterprise customers to grow that line fast. A marketplace with hundreds of thousands of AWS customers is a legitimate attempt to solve that problem without a huge new salesforce.

The stock context matters too. Asure trades about 17% below its 52-week high of $10.20, having been shoved down after the July quarter revealed a swing to a GAAP net loss. An 8.5-times-revenue story this is not; this is a small-cap selling at a deep discount to its large-cap payroll peers, and it needs a narrative driver. The AWS listing is that driver.

Where the growth is (and is not)

The honest numbers behind the 20%-plus headline growth rate: reported revenue rose 23% to $37.1 million in the June quarter, with recurring revenue up 19% to $34.0 million, about 91% of the total. But a large chunk of that reported growth is the enterprise payroll-tax revenue acquired in the Azur deal closing late last year. Organic growth — the number that tells you whether the base business is actually reaccelerating — was 5% in the quarter, up from 1% a year earlier. That is an improvement, but it is also the single reason this stock trades where it does.

The enterprise engine underneath it shows why the channel could be worth more than the optics: 2 million employees from Venture Employer Services are now live on Asure's enterprise tax platform, and core HCM payroll bookings grew 14% year over year in the quarter. Management also points to a contracted backlog of roughly $80 million, with about 41% expected to convert to revenue over the next 12 months. On a $161 million full-year guide, that backlog conversion is not rounding error — it is the difference between a business that grows by acquisition and one that grows on its own. The AWS co-sell attacks the top of that funnel: more qualified enterprise prospects into the sales process, more deals capable of landing in the backlog.

The margin and balance-sheet filter

Growth that never converts to cash is not worth a premium, so the margin progression matters. Adjusted EBITDA — a rough cash-earnings proxy that strips out acquisition charges and stock compensation — rose 48% year over year to $7.7 million in the quarter, lifting the margin to about 21% from 17%. Management's full-year 2026 guidance calls for revenue of $159 million to $163 million at a 24% to 25% adjusted EBITDA margin, which on midpoint math is around $39 million to $40 million of adjusted EBITDA for the year. That is the part of the story the market is not disputing: the bits that generate cash are compounding at a 40%-plus clip.

The GAAP lens is uglier. The June quarter swung to a $0.15 per-share loss where analysts had modeled a small profit, a gap that reads as mostly acquisition-related amortization and interest on the deal financing rather than deterioration in the underlying operations. But it does not read as free money either: cash stood at $19.7 million against $68.9 million of debt as of June 30, leaving roughly $49 million of net debt — about a fifth of the company's market value. Free cash flow turned slightly positive in the quarter at $664,000, which is directionally good but thin. For a serial acquirer that wants to keep buying growth, that leverage is the constraint that could eventually force dilution.

Valuation: cheap for a reason, with a free option attached

Here is the math that makes me a buyer. Asure's market value is roughly $245 million; add the roughly $49 million of net debt and enterprise value comes to about $294 million. Against the $161 million midpoint of the 2026 revenue guide, that is about 1.8 times forward sales, and roughly 7.5 times the ~$39-40 million of adjusted EBITDA implied by management's margin guidance. Paychex trades at about 6.8 times trailing sales and 16 times EV/EBITDA, and ADP at about 5.1 times trailing sales and 17.6 times EV/EBITDA. Asure is not a peer-equal comparison — it is far smaller, slower-growing organically, and levered — but it is also growing reported revenue and EBITDA far faster than either.

The reason the discount is deserved, for now: sell-side consensus models revenue growth of just 7.5% over the next 12 months. The Street is effectively assuming the 23% reported rate collapses toward the 5% organic rate as acquisition comps roll off. That is a coherent bear case, and anyone buying here has to argue it is too pessimistic. The AWS channel and the backlog conversion are the two mechanisms that could prove it wrong — and at 1.8 times forward sales, the market is not charging anything for that outcome. You are paying for the odds, not the base case.

Risks and what would break the thesis

The biggest risk is timing. Co-selling starts in September, and enterprise procurement cycles run in quarters, not weeks. The Q3 print in late October, and probably Q4 as well, will show essentially no AWS-sourced revenue; the payoff, if it comes, is a 2027 story. A buyer here has to be willing to wait through several prints that will not show the channel.

The second risk is that payroll tax is a compliance-and-operations purchase, not a classic cloud consumption line. Some enterprises will happily buy it through the AWS Marketplace; others will keep routing it through their payroll procurement process. The channel could generate respectable pipeline that never fully converts into booked deals — which means the honest test is not listings but disclosed enterprise wins and backlog growth over the next two to four quarters.

The third risk is the balance sheet and the continuation of the GAAP losses. If organic growth stalls at low single digits while the acquisition comps roll off, the 23% reported number will decelerate hard, the guidance could be cut, and a ~1.8 times sales multiple can get cheaper. Persistent losses plus net debt also raise the odds of dilution to fund the next acquisition.

I would reverse this call if organic growth is still in the 5% range a year from now, if the backlog stops converting near the disclosed pace, or if the AWS effort produces no identifiable enterprise wins by early next year. Those are concrete, observable failures — not a vague "execution risk."

Investor takeaway

Buy Asure Software around $8.50. The case does not rest on the press release; it rests on the cheap-enough bridge — about 1.8 times forward sales and roughly 7.5 times forward EBITDA for a business compounding adjusted EBITDA at a 40%-plus rate, with a fresh enterprise distribution channel the market has not priced in. The AWS Marketplace co-sell is the catalyst that could carry organic growth from 5% toward double digits, and the valuation already absorbs the possibility that it does not.

The proof points to monitor are the Q3 report in late October, any disclosed enterprise wins traced to the AWS and co-sell effort, backlog conversion, and the organic growth line on the income statement. If those move the way management's own guidance implies, this stock's discount to Paychex and ADP narrows meaningfully. If they do not, the discount was earned all along — which is precisely why the current price is a fair price to pay for the option.